Author:
Noer Sevria Yetty Anggraina,Sunartini Sunartini,Suryantoro Purnomo
Abstract
Duchenne muscular dystrophy (DMD) is a X-linked recessive gene defect manifesting as a fatal, progressive neuromuscular disease. Treatment goals aim to inhibit disease progression, increase patients’ quality of life, and lengthen life expectancy. We report here a single case of non-ambulatory DMD.
Publisher
Paediatrica Indonesiana - Indonesian Pediatric Society
Subject
Pediatrics, Perinatology and Child Health
Reference33 articles.
1. 1. Emery AE. Population frequencies of inherited neuromuscular diseases-a world survey. Neuromuscul Disord. 1991;1:19-29. DOI: 10.1016/0960-8966(91)90039-u.
2. 2. Romitti PA, Zhu Y, Puzhankara S, James KA, Nabukera SK, Zamba GK, et al. Prevalence of Duschenne and Becker Muscular Dystrophies in the United States. Pediatrics. 2015;135:513-21. DOI:10.1542/peds.2014-2044.
3. 3. Passamano L, Taglia A, Palladino A, Viggiano E, D'Ambrosio, Scutifero M, et al. Improvement of survival in Duchenne Muscular Dystrophy?: retrospective analysis of 835 patients. Acta Myol. 2012;121-5. PMID : 23097603.
4. 4. Van Ruiten HJA, Bettolo MC, Cheetham T, Eagle M, Lochmuller H, Straub V, et al. Why are some patients with Duchenne muscular dystrophy dying young?: An analysis of causes of death in North East England. Eur J Paediatr Neurol. 2016;20:904-9. DOI : 10.1016/j.ejpn.2016.07.0201.
5. 5. Suthar R, Sankhyan N. Duchenne Muscular Dystrophy?: a practice update. Indian J Pediatr. 2018;85:276-81. DOI: 10.1007/s12098-017-2397-y.